Cargando…
Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant—Alzheimer's disease (ASUi005-A) and healthy non-demented control (ASUI006-A)
Although the majority of late-onset Alzheimer's disease (AD) patients are labeled sporadic, multiple genetic risk variants have been identified, the most powerful and prevalent of which is the e4 variant of the Apolipoprotein E (APOE) gene. Here, we generated human induced pluripotent stem cell...
Autores principales: | Brookhouser, Nicholas, Zhang, Ping, Caselli, Richard, Kim, Jean J., Brafman, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217860/ https://www.ncbi.nlm.nih.gov/pubmed/30296667 http://dx.doi.org/10.1016/j.scr.2018.09.007 |
Ejemplares similares
-
Evaluating preference weights for the Asthma Symptom Utility Index (ASUI) across countries
por: Flood, Emuella M, et al.
Publicado: (2006) -
APOE2 mitigates disease-related phenotypes in an isogenic hiPSC-based model of Alzheimer’s disease
por: Brookhouser, Nicholas, et al.
Publicado: (2021) -
hiPSC-Derived Cells as Models for Drug Discovery
por: Ofir, Rivka
Publicado: (2021) -
A mathematical model of hiPSC cardiomyocytes electromechanics
por: Forouzandehmehr, Mohamadamin, et al.
Publicado: (2021) -
Characterizing the secretome of licensed hiPSC-derived MSCs
por: Ramos, Yolande F. M., et al.
Publicado: (2022)